VA: Health and Benefits vs epocrates: Drug Info & Pill ID
Revenue, downloads, ratings and category context for two iOS apps. Figures are estimates and should be read as ranges, not exact totals.
VA: Health and BenefitsUS Department of Veterans Affairs (VA) - Medical
epocrates: Drug Info & Pill IDEpocrates - Medical| Metric | VA: Health and Benefits | epocrates: Drug Info & Pill ID | Readout |
|---|---|---|---|
| Estimated revenue / mo | $*** - opens with trial | $*** - opens with trial | Partial signal |
| Revenue band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Estimated downloads / mo | $*** - opens with trial | $*** - opens with trial | VA: Health and Benefits |
| Download band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Rating | 4.81 | 4.44 | VA: Health and Benefits |
| Rating count | 336k | 7.1k | VA: Health and Benefits |
| Tracked keywords | — | 1 | epocrates: Drug Info & Pill ID |
| Category | Medical | Medical | Same market |
Which app is bigger?
VA: Health and Benefits and epocrates: Drug Info & Pill ID are compared inside Medical with monthly revenue, downloads, rating, review volume, keyword footprint, category placement and range context. VA: Health and Benefits leads on monthly downloads in the current readout, while a clean revenue readout is available only for epocrates: Drug Info & Pill ID in this pair. VA: Health and Benefits wins demand, VA: Health and Benefits has deeper review volume, and epocrates: Drug Info & Pill ID has the larger tracked keyword footprint. The better app depends on the job: choose the revenue leader when you need monetization proof, choose the download leader when reach matters, and choose the higher-rated or deeper-reviewed app when market trust is the constraint. Read both ranges rather than only the midpoint, then open the category hub and related collections to see whether this pair is an outlier or a normal category pattern.